Neuroimaging endpoints in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative, clinically heterogeneous syndrome pathologically overlapping with frontotemporal dementia. To date, therapeutic trials in animal models have not been able to predict treatment response in humans, and the revised Amyotrophic Late...
Main Authors: | Menke, R, Agosta, F, Grosskreutz, J, Filippi, M, Turner, M |
---|---|
Formato: | Journal article |
Publicado em: |
Springer Verlag
2016
|
Registos relacionados
-
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
Por: Turner, M, et al.
Publicado em: (2011) -
Neuroimaging in amyotrophic lateral sclerosis.
Por: Turner, M, et al.
Publicado em: (2012) -
Basal ganglia alterations in amyotrophic lateral sclerosis
Por: Veronica Castelnovo, et al.
Publicado em: (2023-04-01) -
The tough body at the epicentre of amyotrophic lateral sclerosis
Por: Turner, M, et al.
Publicado em: (2017) -
Structural and functional neuroimaging in amyotrophic lateral sclerosis
Por: Ilya S. Bakulin, et al.
Publicado em: (2017-08-01)